Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 4451-4500 of 6039 result(s).
CYDY CytoDyn Inc
12/15/2020 8:36:27 PM
A PR gets wider notice than a confe (1)
CYDY CytoDyn Inc
12/15/2020 8:32:30 PM
I wonder how much leronlimab they w (5)
CYDY CytoDyn Inc
12/15/2020 7:42:03 PM
I am anxious to see how the sock pr (7)
CYDY CytoDyn Inc
12/15/2020 7:09:03 PM
CI, why in heck are you always thin (8)
CYDY CytoDyn Inc
12/15/2020 1:07:59 PM
We're one step ahead of HGEN. From (7)
CYDY CytoDyn Inc
12/15/2020 12:58:57 PM
MAB stands for monoclonal antibody. (1)
CYDY CytoDyn Inc
12/14/2020 5:08:39 PM
He is. (1)
CYDY CytoDyn Inc
12/14/2020 5:05:50 PM
rheumatologist To bad it isn't a ve
CYDY CytoDyn Inc
12/14/2020 4:36:46 PM
Chaired by Johnson, I expect a circ (4)
CYDY CytoDyn Inc
12/14/2020 3:50:21 PM
In fact, InCellDx owes CYDY royalti
CYDY CytoDyn Inc
12/14/2020 1:30:56 PM
any idea if it would help yes (1)
CYDY CytoDyn Inc
12/14/2020 12:17:00 AM
The right to try was for pancreatic
CYDY CytoDyn Inc
12/14/2020 12:03:50 AM
I dare say our trial(s) do NOT read (4)
CYDY CytoDyn Inc
12/13/2020 10:04:11 AM
With the recognition brought by Cov (5)
CYDY CytoDyn Inc
12/12/2020 8:20:19 PM
Slipped up on royalties.
CYDY CytoDyn Inc
12/12/2020 8:16:07 PM
Detail to us the MOAs of leronlimab
CYDY CytoDyn Inc
12/12/2020 7:52:08 PM
I just ran some loose figures for C (16)
CYDY CytoDyn Inc
12/12/2020 7:49:57 PM
I haven't dug down into that compan (1)
CYDY CytoDyn Inc
12/12/2020 6:46:53 PM
That wasn't sarcasm. Compared to wh (1)
CYDY CytoDyn Inc
12/12/2020 9:57:50 AM
A 66% premium from it's near term l (1)
CYDY CytoDyn Inc
12/12/2020 3:00:36 AM
If the problem was that the tests w (1)
CYDY CytoDyn Inc
12/11/2020 5:12:36 PM
That's some short term thinking on (4)
CYDY CytoDyn Inc
12/11/2020 2:35:51 PM
The FDA would want to see any new t (2)
CYDY CytoDyn Inc
12/11/2020 2:32:28 PM
It's not the boom, boom 90's so it' (1)
CYDY CytoDyn Inc
12/11/2020 1:36:15 PM
CYDY is domiciled in Delaware which (2)
CYDY CytoDyn Inc
12/11/2020 1:31:22 PM
In which CC was that said?
CYDY CytoDyn Inc
12/11/2020 12:31:09 PM
Dr. Patterson's test may be a more (2)
CYDY CytoDyn Inc
12/11/2020 12:23:48 PM
Furthermore, the final presentation (2)
CYDY CytoDyn Inc
12/11/2020 12:14:38 PM
I see them establishing preferred a (4)
CYDY CytoDyn Inc
12/11/2020 12:05:01 PM
I would place a significant wager ( (2)
CYDY CytoDyn Inc
12/11/2020 12:01:57 PM
No new test needs to be developed. (9)
CYDY CytoDyn Inc
12/11/2020 11:52:35 AM
No one at CYDY is experienced enoug (5)
CYDY CytoDyn Inc
12/11/2020 11:43:32 AM
No need to develop a new test. Flow (1)
CYDY CytoDyn Inc
12/11/2020 3:04:46 AM
They say it is inflammation that ag (2)
CYDY CytoDyn Inc
12/11/2020 3:02:32 AM
but by then ...we become... what we (2)
CYDY CytoDyn Inc
12/11/2020 1:51:43 AM
But just think of how much leronlim (1)
CYDY CytoDyn Inc
12/11/2020 1:49:14 AM
"so if are biggest concern is OMG t (2)
CYDY CytoDyn Inc
12/11/2020 1:42:27 AM
You are almost certainly correct bu
CYDY CytoDyn Inc
12/11/2020 1:40:56 AM
Why can’t we submit our CD-10 Tri (2)
CYDY CytoDyn Inc
12/11/2020 12:06:04 AM
I would expect trial data should be
CYDY CytoDyn Inc
12/10/2020 9:27:29 PM
Probably most if not all phase 3 co (2)
CYDY CytoDyn Inc
12/10/2020 9:08:01 PM
I missed those posts but if they're (2)
CYDY CytoDyn Inc
12/10/2020 8:59:46 PM
Are Cytodyn's expenses going to be (1)
CYDY CytoDyn Inc
12/10/2020 8:13:18 PM
Logic would indicate that the perso (2)
CYDY CytoDyn Inc
12/10/2020 8:06:06 PM
New type of test, thus patented. It
CYDY CytoDyn Inc
12/10/2020 8:02:40 PM
No announcement of approval (materi
CYDY CytoDyn Inc
12/10/2020 7:58:21 PM
they can seize control of Cytodyn's (4)
CYDY CytoDyn Inc
12/10/2020 7:57:25 PM
Not the balut! (1)
CYDY CytoDyn Inc
12/10/2020 7:55:55 PM
HGEN's falsehood Something I've bee (6)
CYDY CytoDyn Inc
12/10/2020 6:20:15 PM
As I have said over and over again, (9)
Go to page:
  • << First
  • < Previous
  • 89
  • 90
  • Next >

Recent Articles

  • Micron Technology: A Journey of Investment Growth Over 20 Years
  • MIDAS and OLEON Collaborate for Eco-Friendly Data Center Solutions
  • Investor Opportunities: Join the Easterly ROCMuni Class Action
  • Embark on a Unique Winter Experience with Vermejo's Sabbatical
  • Investigating RCI Hospitality Holdings for Shareholder Rights
  • New Leadership at River Valley Community Bancorp: Sinclair Joins Board
  • Transforming a $100 Investment in Barrick Mining Over Years
  • Understanding the Long-Term Growth of Costco Investments
  • Investors Alert: Alto Neuroscience, Inc. Class Action Case Overview
  • ECD Automotive Design Announces Correction for CUSIP Number
  • River Valley Community Bancorp Welcomes New Board Member Robert Sinclair
  • Birmingham's Hispanic Heritage Festival Brings Joy and Unity
  • Woodward, Inc. Declares Cash Dividend for Stockholders
  • GoldHaven Resources Engages in Private Placement Offering
  • Investors Urged to Contact Attorneys Over RxSight Class Action
  • Investor Alert: Legal Claims for Simulations Plus, Inc. Stockholders
  • MetLife's Remarkable Gains: An Investment Journey Revealed
  • GoldHaven Resources Initiates Exciting Equity Financing
  • Understanding the P/E Ratio Implications for Investors
  • Bullish Reports Impressive Second Quarter Revenue Growth
  • Westlawn Americas Offshore Expands with Strategic Acquisition
  • Ontario International Airport Achieves Top Satisfaction Ranking
  • Mounjaro's Promising Phase 3 Trial Results in Young Patients
  • Revolutionary Findings on GLP-1RA Drugs for Psoriasis Patients
  • Dow Inc. Investors Invited to Join Class Action Lawsuit
  • Upwork's Upcoming Investor Day Promises Insightful Perspectives
  • The Impressive Returns of nVent Electric Stock Over Five Years
  • RCI Hospitality Holdings Faces Potential Securities Fraud Inquiry
  • Nucor's Q3 Earnings Forecast: What Investors Should Know
  • Cytokinetics Investors Urged to Join Class Action Lawsuit
  • Semler Scientific Invests in Future Amid Lawsuit Uncertainties
  • Leading Legal Investigation at AppLovin Corp Amid Allegations
  • Brink’s Announces Regular Quarterly Shareholder Dividend Payout
  • Investigation of Semtech Corporation: Support for Shareholders
  • Trading Suspension Notice for Apollomics Inc. on Nasdaq
  • Woodward, Inc. Declares Quarterly Dividend for Shareholders
  • Blue Gold Limited Expands Gold Mining Footprint with New Deal
  • Exploring Caterpillar's Impressive Growth Over Five Years
  • Investors Alert: Key Deadlines for Alto Neuroscience Revealed
  • Brink's Company Announces Regular Quarterly Dividend
  • Legal Scrutiny Looms for Century Aluminum Company Amid Concerns
  • Concerns Raised Over Shoals Technologies' Financial Practices
  • Blue Gold Limited's Strategic Acquisition in Gold and Copper Mining
  • Trading Suspension Update for Apollomics Inc. and Ticker Insights
  • M&T Bank Corporation to Unveil Q3 2025 Earnings Results
  • Investors of Lantheus Holdings Can Join Upcoming Class Action
  • Unlock Your Future: Apply for the Daniels Scholarship Now!
  • Upwork's Upcoming Investor Day: Engage with Company Leaders
  • Xcite Resources Launches New Financing Initiatives for Uranium Projects
  • Soloviev Group's Vision for a Transformative Urban Project
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site